Neurotech International Ltd. (AU:NTI) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments ...

Neurotech International Ltd. (AU:NTI) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments ...

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Sarah Hughan tells all on Neurotech’s (ASX:NTI) vital approval to start its human ...

After hours: November 27 at 6:40 PM EST Loading Chart for DAR ...

To qualify for Breakthrough Device Designation from the US Food and Drug Administration (FDA), a device technology must address an unmet need and provide evidence that it has the potential to provide ...

After hours: November 26 at 4:20 PM EST Loading Chart for MGPI ...

Neurotech International Ltd. has received ethics approval to begin a pharmacokinetic study of its NTI164 drug in healthy adults, an important step for regulatory compliance in both the U.S. and ...

The designation is a result of UNEEG’s strong focus on developing novel disease management support tools with transformational and first-to-market potential To qualify for Breakthrough Device ...

Enjoy exclusive member discounts, giveaways and competitions with our subscriber rewards program.